SLN

SILENCE THERAPEUTICS PLC

Healthcare | Small Cap

-$0.31

EPS Forecast

$5.1

Revenue Forecast

Announcing earnings for the quarter ending 2026-03-31 soon

Proximilar's AI forecasts

EPS Forecast:

-$0.31

Revenue Forecast:

$5.1

EPS Surprise Forecast:

$0.016

Revenue Surprise Forecast:

-$1

Post-release price volatility - High

Post-release Overnight Move:

±9.3%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

57%

Probability of beating revenue consensus:

42%

Probability of beating both EPS & revs consensus:

30%

Probability of missing both EPS & revs consensus:

31%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-2

Beta (β)

Forward Looking Beta (β):

1.29

Earnings volatility

EPS standard deviation:

$0.23

Revenue standard deviation:

$9

As % of share price:

3.62% EXTREME UNCERTAINTY

As % of market cap:

2.95% HIGH

Confidence intervals and percentiles

EPS 95th %ile:

-$0.04

Revenue 95th %ile:

$15

EPS 75th %ile:

-$0.24

Revenue 75th %ile:

$8

EPS 25th %ile:

-$0.38

Revenue 25th %ile:

$3

EPS 5th %ile:

-$0.60

Revenue 5th %ile:

-$4

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

36% MEDIUM

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

45% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$80

Bid-ask per Share:

$0.055